Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • COVID-19 Hospitalizations Rising Among Infants Under Six Months Old, CDC Director Warns

    Bloomberg (11/9, Griffin) reports, “Covid-19 hospitalizations are rising among babies under 6 months old, and the US Centers for Disease Control and Prevention is urging mothers to get vaccinated to reduce the risk of infection in those not yet eligible f...
    Full Article
  • FDA Issues Emergency Use Authorization For Anakinra Injection In Treatment Of COVID-19 Among Hospitalized Adults With Pneumonia Requiring Supplemental Oxygen

    Healio (11/9) reports, “The FDA has issued an emergency use authorization for anakinra injection in the treatment of COVID-19 among hospitalized adults with pneumonia requiring supplemental oxygen.” According to an agency statement, “the EUA is specifical...
    Full Article
  • FDA Panel Votes Against Authorizing Sabizabulin For Treatment Of High-Risk Patients Hospitalized With COVID-19

    Reuters (11/9, Satija, Mahobe) reports “a panel of outside advisers to the” FDA “on Wednesday voted against authorizing Veru Inc’s drug for treating high-risk patients hospitalized with COVID-19, citing multiple concerns over efficacy and safety data bein...
    Full Article
  • Social Determinants Of Health Correlate With Higher Likelihood Of COVID-19-Related Death, Study Finds

    Healio (11/9, Stulpin) reports, “Social determinants of health, including lower socioeconomic status and a higher proportion of racially minoritized groups, correlated with higher likelihood of COVID-19-related death, according to a” study of “data from 1...
    Full Article
  • Novavax Says Omicron BA.1-Tailored COVID-19 Vaccine Shows Strong Immune Response As Fourth Dose

    Reuters (11/8, Satija) reports Novavax on Tuesday “said...its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study.” Study data “showed the...
    Full Article
  • Pfizer-BioNTech COVID-19 Vaccine Tied To Lower Risk Of Developing Myocarditis, Pericarditis Or Myopericarditis Than Moderna Vaccine, Analysis Says

    Cardiovascular Business (11/8) reports, “The Pfizer-BioNTech COVID-19 vaccine is associated with a lower risk of developing myocarditis, pericarditis or myopericarditis than the Moderna Spikevax vaccine, according” to an analysis of “adults who received t...
    Full Article
  • No Secondary Cases Observed In Large Contact Investigation In Response To The First Case Of Monkeypox Virus In US

    HealthDay (11/8) reports, “No secondary cases were observed in a large contact investigation in response to the first case of monkeypox virus (MPXV) infection in the United States.” For the investigation published in the Annals of Internal Medicine, inves...
    Full Article
  • Asian Mosquito Anopheles Stephensi Behind Unprecedented Dry-Season Malaria Outbreak In Ethiopia, Researchers Say

    Healio (11/8, Feller) reports, “The Asian mosquito Anopheles stephensi, linked to a 40-fold increase in malaria cases in Djibouti over the last decade, has been blamed for an unprecedented dry-season malaria outbreak in Ethiopia, according to a study” pre...
    Full Article
  • Uganda To Shorten School Term To Help Curb Ebola Spread

    Reuters (11/8, Biryabarema) reports, “Uganda will shorten the school term by two weeks to reduce daily contact amongst students and help curb the spread of Ebola, the education minister said on Tuesday.” Minister for Education and Sports Janet Kataaha Mus...
    Full Article
  • Study Finds Consistent Increase In Rate Of HPV Vaccinations Per Encounter In Children Aged 9 To 22 Years Despite Overall Decrease In Patient Encounters During COVID-19 Pandemic

    Infectious Disease Advisor (11/8, Lopez) reports, “Despite an overall decrease in the number of patient encounters during the COVID-19 pandemic, there was a consistent increase in the rate of human papillomavirus (HPV) vaccinations per encounter in childr...
    Full Article
  • Nirmatrelvir/Ritonavir May Reduce Risk Of Long COVID, Large Study Suggests

    The Washington Post (11/7, Sellers) reports patients with COVID-19 “who were treated with” nirmatrelvir/ritonavir (Paxlovid), “the oral antiviral that has proved highly effective at preventing hospitalization and death among elderly and at-risk people, ap...
    Full Article
  • Cefoxitin Effective For Treatment Of Patients With Urinary Tract Infection Caused By Extended-Spectrum β-Lactamase-Producing Escherichia Coli, Study Finds

    Infectious Disease Advisor (11/7, Cimino) reports, “Cefoxitin is effective for the treatment of patients with urinary tract infection caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli, with an optimal dose of 2 g every 6 hours via...
    Full Article
  • Neural “Quiet State” May Be Factor Behind Delayed Unconsciousness In Patients With COVID-19 Coming Off Of Ventilators, Anesthesia, Researchers Say

    The New York Times (11/7, Zimmer) reports on patients hospitalized with COVID-19 who recovered and “were taken off” ventilators and anesthesia that “took weeks, and sometimes months, to wake up. But then they usually regained full consciousness, with no s...
    Full Article
  • Many Patients Associated With Disseminated Gonococcal Infections Outbreak In California Lacked Usual Symptoms, Not Included In Screening Groups, Assessment Finds

    Healio (11/7, Stulpin) reports, “Many patients associated with a disseminated gonococcal infections outbreak in California lacked usual symptoms and were not included in the screening groups, according to an outbreak assessment published in Clinical Infec...
    Full Article
  • Second Or Third Dose Of COVID-19 Vaccine Associated With Risk Of Glomerular Disease Relapse, Study Finds

    HealthDay (11/7) reports the risk of glomerular disease relapse is associated with “exposure to a second or third dose of COVID-19 vaccine, according to” researchers who evaluated the “risks of glomerular disease relapse following COVID-19 vaccination in...
    Full Article
  • Pfizer, BioNTech Say Bivalent COVID-19 Booster Shot Safe, Elicits Strong Immune Response After One Month

    USA Today (11/4, Weintraub) reported Pfizer and partner BioNTech “have shown that their new COVID-19 booster does what they hoped it would, with the same safety and side effect profile as earlier shots.” In a study released on Friday, “the pair found that...
    Full Article
  • US Grappling With Early Surge In Flu, RSV Infections, Hospitalizations

    The Washington Post (11/4, Nirappil) reported the US “continues to experience an unusually high and early uptick in flu and respiratory syncytial virus infections, straining a health-care system trying to recover from the worst of the coronavirus pandemic...
    Full Article
  • Children’s Hospitals Across US Confronting Surge In RSV Cases

    The Hill (11/4, Choi) reported, “Children’s hospitals across the country are dealing with a surge in cases of respiratory syncytial virus (RSV), stressing health care services and millions of parents with ailing children.” The article added, “RSV is a com...
    Full Article
  • Omicron Subvariants BQ.1, BQ.1.1 Account For About 35% Of Coronavirus Cases In US, CDC Says

    Reuters (11/4, Mahobe) reported that on Friday, the CDC “estimated that Omicron subvariants BQ.1 and BQ.1.1 accounted for about 35% of coronavirus cases in the country in the week ending Nov.5 compared with 23.2% in the previous week.” The two “subvariant...
    Full Article
  • Children Under Eight Years Of Age At Elevated Risk For Monkeypox Complications, Review Article Contends

    Healio (11/4, Weldon) reported, “Children aged younger than 8 years are at an elevated risk for monkeypox complications and should be considered a high-risk group, according to a review article published in The Pediatric Infectious Disease Journal.” The a...
    Full Article
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id